Evidence map›Paper›PMID 23289765›Full record

Trial reportImmunology2013

CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.

Georgiana M Klug-Micu, Steffen Stenger, Andrea Sommer, Philip T Liu, Stephan R Krutzik, Robert L Modlin, Mario Fabri

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Human LY9 governs CD4Science immunology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Vitamin D as a Shield against Aging.International journal of molecular sciences · 2023
    Review
  15. Review
  16. Different modalities of host cell death and their impact onAmerican journal of physiology. Cell physiology · 2022
    Review
  17. Review
  18. Article
  19. Vitamin D/vitamin D receptor, autophagy, and infection.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Georgiana M Klug-MicuDepartment of Dermatology, University of Cologne, Cologne, Germany.
Steffen Stenger
Andrea Sommer
Philip T Liu
Stephan R Krutzik
Robert L Modlin
Mario Fabri
University of California, Los Angeles · USUniversity of Cologne · DEUniversity Hospital Ulm · DE

Funding

Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4M
Vitamin D Metabolism in LeprosyP50AR063020 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2012 to 2016
$7.8M
ROLE OF TOLL-LIKE RECEPTORS IN SKINR37AI047868 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2000 to 2009
$2.9M
Divergence of Phagocytic and Antimicrobial Programs in LeprosyR01AI047868 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2010 to 2014
$2.4M
Role of Vitamin D Prohormone 25-OHD in the Innate Immune Response to TuberculosisR01AI073539 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2008 to 2012
$2.0M
NIAID NIH HHS AI047868NIAID NIH HHS AI073539NIAID NIH HHS R01 AI022553NIAID NIH HHS R01 AI047868NIAID NIH HHS R01 AI073539NIAID NIH HHS R37 AI047868NIAMS NIH HHS AR040312NIAMS NIH HHS P50 AR063020NIAMS NIH HHS P50 - AR063020NIAMS NIH HHS R01 AR040312
6 · The paper itself

Abstract

The ability of T cells to activate antimicrobial pathways in infected macrophages is essential to host defence against many intracellular pathogens. Here, we compared the ability of two T-cell-mediated mechanisms to trigger antimicrobial responses against Mycobacterium tuberculosis in humans, CD40 activation and the release of interferon-γ (IFN-γ). Given that IFN-γ activates a vitamin D-dependent antimicrobial response, we focused on induction of the key components of this pathway. We show that activation of human monocytes via CD40 ligand (CD40L) and IFN-γ, alone, and in combination, induces the CYP27b1-hydroxylase, responsible for the conversion of 25-hydroxyvitamin D (25D) to the bioactive 1,25-dihydroxyvitamin D (1,25D), and the vitamin D receptor (VDR). The activation of the vitamin D pathway by CD40L and IFN-γ results in up-regulated expression of the antimicrobial peptides, cathelicidin and DEFB4, as well as induction of autophagy. Finally, activation of monocytes via CD40L and IFN-γ results in an antimicrobial activity against intracellular M. tuberculosis. Our data suggest that at least two parallel T-cell-mediated mechanisms, CD40L and IFN-γ, activate the vitamin D-dependent antimicrobial pathway and trigger antimicrobial activity against intracellular M. tuberculosis, thereby contributing to human host defence against intracellular infection.

Indexed as

25-Hydroxyvitamin D3 1-alpha-HydroxylaseAntimicrobial Cationic Peptidesbeta-DefensinsCalcitriolCathelicidinsCD40 LigandFemaleHumansInterferon-gammaMaleMonocytesMycobacterium tuberculosisReceptors, CalcitriolT-LymphocytesTuberculosis25-Hydroxyvitamin D3 1-alpha-HydroxylaseAntimicrobial Cationic Peptidesbeta-DefensinsCalcitriolCathelicidinsCD40 LigandDEFB4A protein, humanIFNG protein, humanInterferon-gammaReceptors, Calcitriol

Identifiers

PMID23289765
PMCPMC3634544
OpenAlexW2086288240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.